METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS Russian patent published in 2010 - IPC A61K31/522 A61K38/21 A61P31/12 

FIELD: medicine.

SUBSTANCE: invention belongs to medicine, notably to infectious diseases and can be used for treatment of infections, induced by herpes simplex viruses type I and II, cytomegalovirus and Epstein-Barr virus. For treatment are used valacyclovir and human recombinant interferon alpha 2. Valacyclovir via ingestion dose is 500 mg twice a day during 5 -10 days. Three million IU of human recombinant interferon alpha 2, diluted in 5 or 10 ml of 0.9% sodium chloride solution is administered twice a day 3 drops into each nostril during 10 days, then 2 drops during 10 days and 1 drop during 10 days.

EFFECT: regimen of human recombinant interferon alpha 2 and valacyclovir administration and dosing aids in increasing of endogenous interferon production resulting in shorter period of infection active phase and longer remission.

1 ex